Clinical Study for Bleomycin Drug-Eluting Beads Transarterial Chemoembolization by large-sized Callispheres Beads in Reach blood supply AML patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023196

Enrollment

Unknown

Registered

2019-05-16

Start date

2019-05-20

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reach blood supply renal angiomyolipoma

Interventions

Case series:Bleomycin Drug-Eluting Beads Transarterial Chemoembolization by Large-sized Callispheres Beads

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Reach blood supply renal angiomyolipoma of more than 5 cm was diagnosed by MRI and CT, accompanied by premature venous manifestation, is not suitable for lipiodol + bleomycin therapy. 2) Informed consent was signed.

Exclusion criteria

Exclusion criteria: 1) Severe renal insufficiency; 2) With malignant renal tumors.

Design outcomes

Primary

Measure	Time frame
Effectiveness;	—

Secondary

Measure	Time frame
Safety;	—

Countries

China

Contacts

Public ContactWang Jian

Peking University First Hospital

vanjian0987@sina.com+86 13520378264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026